근거중심 한국형 우울증 약물학적 치료지침, 개정판(II) : 항우울제의 위약대비 효과, 항우울제간 효과차이 및 효과판정의 적정시점
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 성승환 | - |
dc.contributor.author | 한상우 | - |
dc.contributor.author | 박용천 | - |
dc.contributor.author | 박선철 | - |
dc.contributor.author | 한규만 | - |
dc.contributor.author | 원은수 | - |
dc.contributor.author | 이화영 | - |
dc.contributor.author | 구재우 | - |
dc.contributor.author | 백종우 | - |
dc.contributor.author | 이경민 | - |
dc.contributor.author | 전홍진 | - |
dc.contributor.author | 이문수 | - |
dc.contributor.author | 심세훈 | - |
dc.contributor.author | 고영훈 | - |
dc.contributor.author | 이강준 | - |
dc.contributor.author | 한창수 | - |
dc.contributor.author | 함병주 | - |
dc.contributor.author | 최준호 | - |
dc.contributor.author | 황태연 | - |
dc.contributor.author | 오강섭 | - |
dc.contributor.author | 이민수 | - |
dc.date.accessioned | 2021-09-06T07:30:42Z | - |
dc.date.available | 2021-09-06T07:30:42Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1015-4817 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105027 | - |
dc.description.abstract | Objectives The purpose of this study was to suggest recommendations of antidepressant efficacy compared with placebo, difference in efficacy of antidepressants, and appropriate time of efficacy judgment in antidepressant therapy. Methods Using recommendations from 12 international and domestic clinical practice guidelines for depression, drawing of recommendation drafts, and peer review, the executive committee developed the guideline. Results Tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOI), selective serotonin reuptake inhibitors (SSRI), serotonin and norepinephrine reuptake inhibitors (SNRIs), norepinephrine and specific serotonergic antidepressants (NaSSAs), norepinephrine and dopamine reuptake inhibitors (NDRIs), and serotonin antagonist and reuptake inhibitors (SARIs) were strongly recommended as having antidepressant efficacy compared with placebo. Difference in efficacy of antidepressants was as follows. TCAs, MAOI, SSRI, SNRIs, and NaSSAs were strongly recommended, however, NDRIs, SARIs were weakly recommended. If there was no or minimal improvement with treatment, appropriate time of efficacy judgment in antidepressant therapy was estimated to be after two to four weeks. Conclusion We hope that the results of this study will be helpful in encouraging the optimal treatment by understanding antidepressant efficacy compared with placebo, difference in efficacy of antidepressants, and appropriate time of efficacy judgment in antidepressant therapy. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한신경정신의학회 | - |
dc.title | 근거중심 한국형 우울증 약물학적 치료지침, 개정판(II) : 항우울제의 위약대비 효과, 항우울제간 효과차이 및 효과판정의 적정시점 | - |
dc.title.alternative | Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (II) : Antidepressant Efficacy Compared with Placebo, Difference in Efficacy of Antidepressants, and Appropriate Time of Efficacy Judgment in Antidepressant Therapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 한규만 | - |
dc.contributor.affiliatedAuthor | 이문수 | - |
dc.contributor.affiliatedAuthor | 이민수 | - |
dc.identifier.bibliographicCitation | 신경정신의학, v.52, no.5, pp.372 - 385 | - |
dc.relation.isPartOf | 신경정신의학 | - |
dc.citation.title | 신경정신의학 | - |
dc.citation.volume | 52 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 372 | - |
dc.citation.endPage | 385 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001812129 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | 우울증 | - |
dc.subject.keywordAuthor | 진료지침 | - |
dc.subject.keywordAuthor | 항우울제 | - |
dc.subject.keywordAuthor | 위약 | - |
dc.subject.keywordAuthor | 효과 차이 | - |
dc.subject.keywordAuthor | 효과판정 | - |
dc.subject.keywordAuthor | 적정시점. | - |
dc.subject.keywordAuthor | Major depressive disorder | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Antidepressant | - |
dc.subject.keywordAuthor | Placebo | - |
dc.subject.keywordAuthor | Difference in efficacy | - |
dc.subject.keywordAuthor | Appropriate time | - |
dc.subject.keywordAuthor | Efficacy judgment. | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.